14โ€“17 Sept 2025
Palace of Culture and Science
Europe/Warsaw timezone

Session

Industrial Session

16 Sept 2025, 13:30
Ratuszowa

Ratuszowa

Conveners

Industrial Session

  • Tal Yehiel

Description

Sponsors:
- CollPlant
- Polbionica
- BioCloner Health
- BIOinx
- BIO3DPrinting

Presentation materials

There are no materials yet.

  1. Shirel Cohen (Collplant)
    16/09/2025, 13:30
    podium presentation

    rhCollagen Bioinks for Biofabrication
    Cohen S.; Noor N.; Seror J.; Olami H.; Braiman U. Grienberg R. Ioffe K; Buravenkov V. and
    Gazal E.
    CollPlant Biotechnologies Ltd., 4 Oppenheimer St, Rehovot, Israel

    Introduction

    Bioinks are a cornerstone of 3D bioprinting, providing the essential biological and mechanical framework required for the precise deposition of living cells, biomaterials,...

    Go to contribution page
  2. Maciej Szurek (Polbionica S.A.)
    16/09/2025, 14:00
    podium presentation

    Biomaterials and Bioreactor with ISO 13485 Standards โ€“ Reliable Tools for Everyday Research.
    One of the biggest challenges in organoid and tissue engineering research is reproducibility. Small changes in bioinks composition or inconsistent bioreactor settings often lead to different results, even when protocols are similar. This slows down projects and makes it hard to compare data across...

    Go to contribution page
  3. Maciej Tabiszewski (BioCloner Health)
    16/09/2025, 14:15
    podium presentation

    The rapid evolution of biomedical technologies is transforming both research and clinical practice, creating new opportunities to improve both human and animal health. BioCloner Health develops a multifunctional system for biofabrication that integrates tools, platforms, and processes to bridge the gap between scientific discovery and practical application. The focus is on purposeful...

    Go to contribution page
  4. Aysu Arslan (BIO INX BV)
    16/09/2025, 14:30
    podium presentation

    Bioprinting has rapidly advanced into a key enabling technology for biomedical research, offering unique capabilities to fabricate complex biological architectures with high precision and adaptability. Its versatility spans a wide range of resolutions, making it possible to construct both large-scale scaffolds and finely detailed microstructures. Central to the success of this approach is the...

    Go to contribution page
  5. Ginevra Pegollo (Bio3DPrinting)
    16/09/2025, 14:40
    podium presentation

    Bioprinting has made remarkable progress in the fabrication of functional tissues and organ constructs, ushering in a new era of personalized medicine with applications in transplantation, drug testing, research, and disease modeling. Bio3DPrinting has taken a significant step towards clinical translation by introducing Electrospider, a bioprinting ecosystem engineered for versatile multiscale...

    Go to contribution page
Building timetable...